Open AccessPersistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer
Author(s) -
Amy Tang,
Richard Hoefer,
Mary L. Guye,
Harry D. Bear
Publication year - 2022
Publication title -
cancer drug resistance
Language(s) - English
Resource type - Journals
ISSN - 2578-532X
DOI - 10.20517/cdr.2022.31
Subject(s) - triple negative breast cancer , breast cancer , oncology , medicine , pembrolizumab , cancer , immune checkpoint , chemotherapy , cancer research , immunotherapy